JACKSONVILLE, Fla., U.S.: Scientists have recently discovered that an oral rinse referred to as magic mouthwash significantly reduces the pain caused by oral mucositis and mouth ulcers in patients receiving radiation therapy for head and neck cancers. The mouthwash contains diphenhydramine, lidocaine and antacids.
The study was led by Dr. Robert C. Miller, Professor of Radiation Oncology at Mayo Clinic. The findings emerged from a multi-institutional randomized, double-blind, placebo-controlled Phase III clinical trial.
“Our group published a study in 2012 showing that an oral rinse of doxepin reduced oral mucositis-related pain, compared to placebo,” said Miller. “However, there were no large randomized controlled trials studying the potential benefits of magic mouthwash.”
In the new study, conducted between November 2014 and May 2016, Miller and his colleagues studied 275 patients who underwent definitive head and neck radiotherapy and had an oral mucositis pain score of 4 points or greater. The participants were followed up for a maximum of 28 days. The research team found that pain related to oral mucositis was reduced by 11.6 points after using doxepin mouthwash and by 11.7 points after using diphenhydramine-lidocaine-antacid mouthwash, within 4 hours of administration. There was a reduction of 8.7 points for placebo mouthwash. Both experimental rinses were also well-tolerated by patients.
“Radiation therapy may cause mouth sores because it is designed to kill rapidly growing cells, such as cancer cells,” said co-author Dr. Terence T. Sio, a radiation oncologist at the clinic. “Unfortunately, healthy cells in your mouth also divide and grow rapidly, and may be damaged during radiation therapy, which can cause discomfort. We’re glad to have identified a proven method to help treat the discomfort of this side effect,” he concluded.
The study, titled “Effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain: The Alliance A221304 randomized clinical trial,” was published online on April 16, 2019, in JAMA.
Tags:
HEIDELBERG, Germany: When a patient requires orthodontic treatment, it is common practice to capture the dental malposition with a radiograph. Scientists ...
BELAGAVI, India: An adapted approach is required to train children with visual impairment in oral hygiene and to motivate them to care for their teeth ...
SYDNEY, Australia: The underlying causes of central sensitisation disorders such as migraine and fibromyalgia are poorly understood. The gut–brain axis ...
SALT LAKE CITY, U.S.: Research indicates that people who suffer from substance use disorder (SUD) generally have poor oral health, which also damages ...
COLOGNE, Germany: Fotona’s SWEEPS (shock wave-enhanced emission photoacoustic streaming) is a revolutionary means of cleaning and disinfecting the root ...
A main cause of endodontic failure is the recolonisation of the poorly treated root canal system with micro-organisms. The primary goal of endodontic ...
TAIPEI, Taiwan: The debate on climate change and its effects on the earth are a hot topic. One discussion, in particular, is around air pollution, which is ...
BALTIMORE, U.S: Scientists investigating the potential health effects of vaping on the human pulmonary system have reported that inhaling vapor from ...
ORLANDO, Fla., U.S.: In a new study, researchers compared the oral health status of women with preterm prelabor rupture of membranes (PPROM) and women with ...
CLEVELAND, U.S.: Safe and effective pain management is an important topic for dental practitioners. Opioid and nonopioid analgesic agents are among the ...
Live webinar
Thu. 11 September 2025
1:00 pm EST (New York)
Live webinar
Mon. 15 September 2025
1:00 pm EST (New York)
Prof. Dr. med. dent. Stefan Wolfart
Live webinar
Tue. 16 September 2025
11:00 am EST (New York)
Prof. Dr. Dr. Florian Guy Draenert
Live webinar
Tue. 16 September 2025
12:30 pm EST (New York)
Dr. Kay Vietor, Birgit Sayn
Live webinar
Tue. 16 September 2025
1:00 pm EST (New York)
Dr. Paweł Aleksandrowicz PhD
Live webinar
Tue. 16 September 2025
8:00 pm EST (New York)
Live webinar
Wed. 17 September 2025
6:30 am EST (New York)
To post a reply please login or register